Riboflavin and ultraviolet light: impact on dengue virus infectivity

Vox Sanguinis

Volumn 111, Issue 3, 2016, Pages 235-241

  Faddy, H M ^a,b   Fryk, J J ^a   Watterson, D ^b   Young, P R ^b   Modhiran, N ^b   Muller, D A ^b   Keil, S D ^c   Goodrich, R P ^c   Marks, D C ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Terumo BCT   (United States)

Author keywords

dengue; emerging infectious disease; pathogen inactivation; safety; transfusion

Indexed keywords

RIBOFLAVIN; THROMBOCYTE CONCENTRATE; PHOTOSENSITIZING AGENT; VIRUS RNA;

ANIMAL CELL; ARTICLE; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; SEROTYPE; ULTRAVIOLET RADIATION; VIRUS INACTIVATION; VIRUS INFECTIVITY; BLOOD SAFETY; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE; THROMBOCYTE TRANSFUSION; VIROLOGY;

BLOOD PLATELETS; BLOOD SAFETY; DENGUE VIRUS; HUMANS; PHOTOSENSITIZING AGENTS; PLATELET TRANSFUSION; REAL-TIME POLYMERASE CHAIN REACTION; RIBOFLAVIN; RNA, VIRAL; SEROGROUP; ULTRAVIOLET RAYS; VIRUS INACTIVATION;

EID: 84992026462     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12414     Document Type: Article

References (31)

1. Fitzsimmons GJ, Wright P, Johansen CA, et al.: Arboviral diseases and malaria in Australia, 2008–09: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell Q Rep 2010; 34:225–240
2. Guzman MG, Halstead SB, Artsob H, et al.: Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8:S7–S16
3. Radke EG, Gregory CJ, Kintziger KW, et al.: Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis 2012; 18:135–137
4. Bhatt S, Gething PW, Brady OJ, et al.: The global distribution and burden of dengue. Nature 2013; 496: 504–507
5. Tambyah PA, Koay ES, Poon ML, et al.: Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008; 359:1526–1527
6. Chuang V, Wong TY, Leung YH, et al.: Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008; 14:170–177
7. Levi JE, Nishiya A, Felix AC, et al.: Real-time symptomatic case of transfusion-transmitted dengue. Transfusion 2015; DOI: 10.1111/trf.12944
8. Stramer SL, Linnen JM, Carrick JM, et al.: Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012; 52:1657–1666
9. Sabino EC, Loureiro P, Lopes ME, et al.: Transfusion-Transmitted Dengue and Associated Clinical Symptoms During the 2012 Epidemic in Brazil. J Infect Dis 2016; 213:694–702
10. Oh HB, Muthu V, Daruwalla ZJ, et al.: Bitten by a bug or a bag? Transfusion-transmitted dengue: a rare complication in the bleeding surgical patient. Transfusion 2015; 55:1655–1661
11. Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480–496
12. Mustafa MS, Rasotgi V, Jain S, et al.: Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control. Med J Armed Forces India 2015; 71:67–70
13. Health Q: Current dengue outbreaks. 24th July 2013, 2013. http://www.health.qld.gov.au/dengue/outbreaks/current.asp (Last accessed September 23 2013).
14. Beebe NW, Cooper RD, Mottram P, et al.: Australia's dengue risk driven by human adaptation to climate change. PLoS Negl Trop Dis 2009; 3:e429
15. Potter S: The Sting of Climate Change: Malaria and Dengue Fever in Maritime Southeast Asia and the Pacific Islands. Policy Brief, Lowy Institute for International Policy, 2008
16. Russell RC, Currie BJ, Lindsay MD, et al.: Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust 2009; 190:265–268
17. Faddy HM, Seed CR, Fryk JJ, et al.: Implications of dengue outbreaks for blood supply, Australia. Emerg Infect Dis 2013; 19:787–789
18. Marks DC, Faddy HM, Johnson L: Pathogen reduction technologies. ISBT Sci Series 2014; 9:44–50
19. Marschner S, Goodrich R: Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfus Med Hemother 2011; 38:8–18
20. Ruane PH, Edrich R, Gampp D, et al.: Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44:877–885
21. Keil SD, Bengrine A, Bowen R, et al.: Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment. Transfusion 2015; 55:1736–1744
22. Vanlandingham DL, Keil SD, Horne KM, et al.: Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system. Transfusion 2013; 53:284–290
23. Faddy HM, Prow NA, Fryk JJ, et al.: The effect of riboflavin and ultraviolet light on the infectivity of arboviruses. Transfusion 2014; 55:824–831
24. Johnson L, Winter KM, Reid S, et al.: The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011; 101:208–214
25. Faddy HM, Fryk JJ, Prow NA, et al.: Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light. Transfusion 2016; DOI: 10.1111/trf.13519
26. Watterson D, Kobe B, Young PR: Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J Gen Virol 2012; 93:72–82
27. Musso D, Richard V, Broult J, et al.: Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2014; 54:2924–2930
28. Orozco S, Schmid MA, Parameswaran P, et al.: Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol 2012; 93:2152–2157
29. Moi ML, Lim CK, Kotaki A, et al.: Detection of higher levels of dengue viremia using FcgammaR-expressing BHK-21 cells than FcgammaR-negative cells in secondary infection but not in primary infection. J Infect Dis 2011; 203:1405–1414
30. van der Schaar HM, Rust MJ, Waarts BL, et al.: Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 2007; 81:12019–12028
31. Simon AY, Sutherland MR, Pryzdial EL: Dengue virus binding and replication by platelets. Blood 2015; 126:378–385